Historical record - last NADAC publication: 2/21/2024
Product Information
ERY-TAB DR 250 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $3.8591 per EA under NDC 24338012213. Its NADAC has been published 511 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338012213
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
2/21/2024
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298On Market Since
4/18/2011
Pharmacological Classes
Price Statistics
The NADAC for ERY-TAB DR 250 MG TABLET has been published 511 times since Nov 28, 2013, and over the history we have for it it has risen 91.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.8591 per EA |
|---|---|
| All-time high | $7.0949 (Jul 10, 2019) |
| All-time low | $2.0176 (Nov 28, 2013) |
| Median price | $5.4553 |
| Average price | $5.2720 |
| Largest weekly change | +41.1% (Mar 22, 2023) |
| Weeks tracked | 511 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 55% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERY-TAB DR 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 250 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $3.8591 per EA (NDC 24338012213), effective Mar 6, 2024.
How has the price of ERY-TAB DR 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERY-TAB DR 250 MG TABLET has risen 91.3%. It has been tracked across 511 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERY-TAB DR 250 MG TABLET?
Since Nov 28, 2013, the NADAC for ERY-TAB DR 250 MG TABLET has ranged from a low of $2.0176 (Nov 28, 2013) to a high of $7.0949 (Jul 10, 2019), with a median of $5.4553 per EA.
Are there cheaper alternatives to ERY-TAB DR 250 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.7409 per EA — about 55% below ERY-TAB DR 250 MG TABLET.
Who manufactures ERY-TAB DR 250 MG TABLET?
ERY-TAB DR 250 MG TABLET (NDC 24338012213) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification